Probiotic compositions containing clostridiales for inhibiting inflammation
US9610307B2 · kind B2 · utility
113Cited by
4References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 25, 2015 |
| Grant date | Apr 4, 2017 |
| Priority date | — |
| Expiry date | Nov 25, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions containing microbial entities are described herein. The pharmaceutical compositions may optionally contain or be used in conjunction with one or more prebiotics. Uses of the pharmaceutical compositions to treat or prevent disorders of the local or systemic microbiome in a subject are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.